Qureight Vascul8 model for pulmonary vascular disorders validated in peer-reviewed study, offering potential to improve treatment options and patient outcomes following surgery

Previous
Previous

UK SPACE COMPANIES' PARTNERSHIP COMPLETED THE DEVELOPMENT OF AN ADVANCED DEPLOYABLE SAR ANTENNA PAYLOAD

Next
Next

Tenyks’ pioneering AI video tech delivers big gains for retail and hospitality firms